| ASSET | MONTH | % RETURN |
|---|---|---|
Glaukos (GKOS) | August 2018 | 64.87% |
Kiniksa Pharmaceuticals (KNSA) | August 2018 | 57.32% |
Applied Digital (APLD) | August 2018 | 56% |
Denali Therapeutics (DNLI) | August 2018 | 55.79% |
Workiva (WK) | August 2018 | 46.23% |
Skeena Resources (SKE) | August 2018 | 45.44% |
GDS (GDS) | August 2018 | 39.51% |
Liquidia Technologies (LQDA) | August 2018 | 39.45% |
Match (MTCH) | August 2018 | 39.14% |
Protagonist Therapeutics (PTGX) | August 2018 | 38.76% |
United Parks & Resorts (PRKS) | August 2018 | 38.37% |
Paylocity Holdng (PCTY) | August 2018 | 36.87% |
Wingstop (WING) | August 2018 | 36.32% |
IAC (IAC) | August 2018 | 34.64% |
Paycom Software (PAYC) | August 2018 | 33.67% |
Axsome Therapeutics (AXSM) | August 2018 | 32.69% |
Xenon Pharmaceuticals (XENE) | August 2018 | 32.5% |
Alarm (ALRM) | August 2018 | 31.3% |
Spyre Therapeutics (SYRE) | August 2018 | 30.12% |
Boot Barn (BOOT) | August 2018 | 28.68% |
Freshpet (FRPT) | August 2018 | 28.32% |
Viking Therapeutics (VKTX) | August 2018 | 27.39% |
Bel Fuse B (BELFB) | August 2018 | 27.33% |
Nektar Therapeutics (NKTR) | August 2018 | 26.99% |
Ringcentral (RNG) | August 2018 | 26.31% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
